LuciBelzu 40 mg Tablet
Prescription Required
Brand Name:
LuciBelzu
Molecule:
BelzutifanStrength:
40 mg
Quantity:
90 Tablets
Form:
Tablet
Packaging Type:
Bottle
Manufacturer/Marketed By:
Lucius PharmaCountry of Origin:
Laos
Enquiry Form
No similar products found.
Description
Active Ingredient: Each tablet contains Belzutifan 40 mg.
Indications: LuciBelzu is a hypoxia-inducible factor (HIF) inhibitor indicated for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated:
-
Renal cell carcinoma (RCC)
-
Central nervous system (CNS) hemangioblastomas
-
Pancreatic neuroendocrine tumors (pNET)
Note: Not intended for patients requiring immediate surgery.
Dosage & Administration:
-
Recommended dose: 120 mg (three 40 mg tablets) taken orally once daily, with or without food.
-
Swallow tablets whole; do not crush or split.
Related Products
Lucirux Ruxolitinib 5 mg Tablet
Molecule: Ruxolitinib
Manufacturer: Lucius Pharma
Ask for Price
Enquiry Form
Related Posts:
No matching posts found.
Reviews
Clear filtersThere are no reviews yet.